GLYSENNID Side Effects

7012629-5 | Abdominal Pain, Abdominal Tenderness, Blood Amylase Increased, Body Temperature Decreased, C-reactive Protein Decreased, Diarrhoea, Lipase Increased, Pancreatic Enzymes Increased
on Sep 13, 2010 Female patient from JAPAN , weighting 120.2 lb, was diagnosed with hepatic neoplasm malignant and was treated with Glysennid (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), abdominal tenderness, blood amylase increased, body temperature decreased, c-reactive protein decreased, diarrhoea, lipase increased, pancreatic enzymes increased. Glysennid dosage: Unk, Unk. During the same period patient was treated with SORAFENIB (400 Mg, Bid) (View Sorafenib Review and Sorafenib Label ), GLYCYOL (Unk) (View Glycyol Review and Glycyol Label ), SAWADOL L (Unk) (View Sawadol L Review and Sawadol L Label ), D ALFA (Unk) (View D Alfa Review and D Alfa Label ), NIFELAT L (Unk) (View Nifelat L Review and Nifelat L Label ), RETICOLAN (Unk) (View Reticolan Review and Reticolan Label ), ASPARA CA (Unk) (View Aspara-ca Review and Aspara-ca Label ). Patient was hospitalized.

7012623-4 | Infertility
Patient was taking Glysennid (View Usage). Patient had the following side effects: infertility (What is infertility?) on Sep 17, 2010 from JAPAN Additional patient health information: Female patient , 36 years of age, was diagnosed with constipation (What is constipation?) and. Glysennid dosage: Unk, Unk.

6661390-2 | Lung Disorder
Adverse event was reported on Mar 25, 2010 by a Female patient taking Glysennid (View Usage) (Dosage: Unk,unk) was diagnosed with constipation (What is constipation?) and. Location: JAPAN , 73 years of age, After Glysennid was administered, patient had the following side effects: lung disorder. During the same period patient was treated with RISPERDAL (Unk,unk) (View Risperdal Review and Risperdal Label ), ROHYPNOL (Unk,unk) (View Rohypnol Review and Rohypnol Label ), LENDORMIN (Unk,unk) (View Lendormin Review and Lendormin Label ), TETRAMIDE (Unk,unk) (View Tetramide Review and Tetramide Label ), ADALAT (Unk,unk) (View Adalat Review and Adalat Label ), RENIVACE (Unk,unk) (View Renivace Review and Renivace Label ), OMEPRAL (Unk,unk) (View Omepral Review and Omepral Label ), THEO DUR (Unk,unk) (View Theo-dur Review and Theo-dur Label ).

6656571-8 | Lung Disorder
on Mar 19, 2010 Female patient from JAPAN , 73 years of age, was treated with Glysennid (View Usage). Patient experienced the following unwanted or unexpected effects: lung disorder. Glysennid dosage: Unk,unk.


5766089-2 | Interstitial Lung Disease, Pancytopenia
on Jun 06, 2008 Male patient from JAPAN , weighting 100.8 lb, was diagnosed with constipation (What is constipation?), cerebral infarction, insomnia and was treated with Glysennid (View Usage). Patient had the following side effects: interstitial lung disease, pancytopenia. Glysennid dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ).

5704702-6 | Mesenteric Occlusion
Patient was taking Glysennid (View Usage). After Glysennid was administered, patient had the following side effects: mesenteric occlusion on Apr 08, 2008 from JAPAN Additional patient health information: Female patient , weighting 90.39 lb, was diagnosed with hypertension, cerebrovascular disorder and. Glysennid dosage: 36 Mg. During the same period patient was treated with SELBEX (150 Mg) (View Selbex Review and Selbex Label ), SEVEN EP (3 Capsules) (View Seven Ep Review and Seven Ep Label ), ALLEGRA (120 Mg) (View Allegra Review and Allegra Label ), FERROMIA (100 Mg) (View Ferromia Review and Ferromia Label ), AMLODIN (5 Mg) (View Amlodin Review and Amlodin Label ), BLOPRESS (8 Mg) (View Blopress Review and Blopress Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

5701597-1 | Delirium, Hallucination, Visual, Somnambulism
Adverse event was reported on Apr 03, 2008 by a Female patient taking Glysennid (View Usage) (Dosage: Unk) was diagnosed with insomnia and. Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: delirium, hallucination, visual, somnambulism. During the same period patient was treated with URSO 250 (Unk) (View Urso 250 Review and Urso 250 Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), GASTER D (Unk) (View Gaster D Review and Gaster D Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MYSLEE (View Myslee Review and Myslee Label ).

5697968-2 | Mesenteric Occlusion
on Sep 11, 2007 Female patient from JAPAN , weighting 90.39 lb, was diagnosed with hypertension, cerebrovascular disorder and was treated with Glysennid (View Usage). Patient had the following side effects: mesenteric occlusion. Glysennid dosage: 36 Mg. During the same period patient was treated with SELBEX (150 Mg) (View Selbex Review and Selbex Label ), SEVEN EP (3 Capsules) (View Seven Ep Review and Seven Ep Label ), ALLEGRA (120 Mg) (View Allegra Review and Allegra Label ), FERROMIA (100 Mg) (View Ferromia Review and Ferromia Label ), AMLODIN (5 Mg) (View Amlodin Review and Amlodin Label ), BLOPRESS (8 Mg) (View Blopress Review and Blopress Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

5692003-4 | Mesenteric Occlusion
on Sep 11, 2007 Female patient from JAPAN , weighting 90.39 lb, was diagnosed with hypertension, cerebrovascular disorder and was treated with Glysennid (View Usage). After Glysennid was administered, patient had the following side effects: mesenteric occlusion. Glysennid dosage: 36 Mg. During the same period patient was treated with SELBEX (150 Mg) (View Selbex Review and Selbex Label ), SEVEN EP (3 Capsules) (View Seven Ep Review and Seven Ep Label ), ALLEGRA (120 Mg) (View Allegra Review and Allegra Label ), FERROMIA (100 Mg) (View Ferromia Review and Ferromia Label ), AMLODIN (5 Mg) (View Amlodin Review and Amlodin Label ), BLOPRESS (8 Mg) (View Blopress Review and Blopress Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

5649539-1 | Delirium, Hallucination, Visual, Somnambulism
Patient was taking Glysennid (View Usage). Patient experienced the following unwanted or unexpected effects: delirium, hallucination, visual, somnambulism on Feb 26, 2008 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with insomnia and. Glysennid dosage: Unk. During the same period patient was treated with URSO 250 (Unk) (View Urso 250 Review and Urso 250 Label ), FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MYSLEE (View Myslee Review and Myslee Label ).